Literature DB >> 1624969

Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12 year follow-up report.

H A Majeed1, S Batnager, A M Yousof, F Khuffash, A R Yusuf.   

Abstract

Sixty four children who presented with the initial attack of acute rheumatic fever and maintained continuous regular secondary prophylaxis, were followed up prospectively for 12.3 years (an observation period of 775 patient-years). The prevalence rate of rheumatic heart disease in the 29 children who had carditis in the initial attack and in the 35 children who had no carditis initially was 49 vs 0%, respectively. The overall prevalence rate of rheumatic heart disease was 20%. Mitral incompetence developed in 11 patients (17%), aortic incompetence in 2 (3%) and mitral stenosis in 2 (3%). None of the patients developed aortic stenosis. Two recurrences developed with a recurrence rate of 0.003 per patient per year. One patient needed cardiac surgery and there was no mortality. These data strongly suggest that continuous regular secondary prophylaxis can prevent or significantly reduce the development of mitral and aortic valve stenosis, the prevalence rate of rheumatic heart disease and mortality.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624969     DOI: 10.1016/0895-4356(92)90070-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  18 in total

Review 1.  Prevention and treatment of rheumatic heart disease in the developing world.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Nat Rev Cardiol       Date:  2009-09-15       Impact factor: 32.419

2.  Secondary prophylaxis is important for the prevention of recurrent rheumatic fever in the Pacific.

Authors:  Andrew C Steer; Samantha Colquhoun; Joseph Kado; Jonathan R Carapetis
Journal:  Pediatr Cardiol       Date:  2011-08       Impact factor: 1.655

3.  Decreased Prevalence of Rheumatic Heart Disease Confirmed Among HIV-positive Youth.

Authors:  Ian W Hovis; Judith Namuyonga; Grace P Kisitu; Emma Ndagire; Emmy Okello; Chris T Longenecker; Amy Sanyahumbi; Craig A Sable; Daniel J Penny; Peter Lwabi; Adeodata R Kekitiinwa; Andrea Beaton
Journal:  Pediatr Infect Dis J       Date:  2019-04       Impact factor: 2.129

4.  Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.

Authors:  Justin P Zachariah; Mihail Samnaliev
Journal:  J Med Econ       Date:  2015-02-09       Impact factor: 2.448

Review 5.  Screening for rheumatic heart disease: current approaches and controversies.

Authors:  Kathryn Roberts; Samantha Colquhoun; Andrew Steer; Bo Reményi; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

6.  Use of Doppler echocardiography to support the decision to discontinue secondary prophylaxis for patients with rheumatic fever and normal cardiac auscultation.

Authors:  Fátima Derlene da Rocha Araújo; Eugênio Marcos de Andrade Goulart; Zilda Maria Alves Meira
Journal:  Pediatr Cardiol       Date:  2012-12-13       Impact factor: 1.655

7.  Echocardiographic pattern and severity of valve dysfunction in children with rheumatic heart disease seen at Uganda Heart Institute, Mulago hospital.

Authors:  Sulaiman Lubega; Twalib Aliku; Peter Lwabi
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

Review 8.  Penicillin for secondary prevention of rheumatic fever.

Authors:  J Manyemba; B M Mayosi
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  Rheumatic Fever and Long-term Sequelae in Children.

Authors:  Anita Saxena
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-08

10.  Failure of oral penicillin as secondary prophylaxis for rheumatic heart disease: a lesson from a low-prevalence rheumatic fever region.

Authors:  S M McGlacken-Byrne; H M Parry; P F Currie; N J Wilson
Journal:  BMJ Case Rep       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.